Signup Crypto ETF Stocks News

ShiftKey Promotes Seth Rosenberg to President and Chief Operating Officer

DALLAS, June 10, 2025 ( GLOBE NEWSWIRE ) -- ShiftKey, a leading technology marketplace revolutionizing workforce access in healthcare and beyond, is pleased to announce the promotion of Seth Rosenberg to President and Chief Operating Officer.

Source: www.benzinga.com
June 10, 2025 | 14:30:00
Category: News

Nika Pharmaceuticals, Inc. to Present at the Life Sciences Virtual Investor Forum June 11th-12th - Nika Pharmaceuticals ( OTC:NIKA )

HENDERSON, Nev., June 10, 2025 ( GLOBE NEWSWIRE ) -- Nika Pharmaceuticals, Inc. NIKA, based in Colorado, focused on cures for life-threatening diseases, today announced that Dimitar Savov, CEO, will present live at the Life Sciences Virtual Investor Frum hosted by VirtualInvestorConferences.com, ...

Source: www.benzinga.com
June 10, 2025 | 14:30:00
Category: News

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - O'Reilly Automotive ( NASDAQ:ORLY )

O'Reilly Automotive ORLY has outperformed the market over the past 5 years by 12.12% on an annualized basis producing an average annual return of 26.49%. Currently, O'Reilly Automotive has a market capitalization of $5.11 billion.

Source: www.benzinga.com
June 10, 2025 | 14:30:14
Category: News

Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ ( bevacizumab gamma ) for the Treatment of Wet AMD - Outlook Therapeutics ( NASDAQ:OTLK )

ISELIN, N.J., June 10, 2025 ( GLOBE NEWSWIRE ) -- Outlook Therapeutics, Inc.

Source: www.benzinga.com
June 10, 2025 | 12:05:00
Category: General

Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ ( bevacizumab gamma ) for the Treatment of Wet AMD

Outlook Therapeutics® Announces SMC Recommendation of LYTENAVAâ„¢ (bevacizumab gamma) for the Treatment of Wet ...

Source: markets.businessinsider.com
June 10, 2025 | 12:05:00
Category: RSS

Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ ( bevacizumab gamma ) for the Treatment of Wet AMD

ISELIN, N.J., June 10, 2025 ( GLOBE NEWSWIRE ) -- Outlook Therapeutics, Inc. ( Nasdaq: OTLK ) , a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the Scottish Medicines Consortium ( SMC ) acceptance of ...

Source: www.globenewswire.com
June 10, 2025 | 12:05:00
Category: News

EQS-CMS: Scout24 SE: Release of a capital market information

EQS Post-admission Duties announcement: Scout24 SE / Announcement corresponding to Art. 5 para. 1 lit. b ) , para. 3 of Regulation ( EU ) No 596/2014 in its current version and Art. 2 para. 3 of Delegated Regulation ( EU ) 2016/1052 Scout24 SE: Release of a capital market information

Source: markets.businessinsider.com
June 10, 2025 | 12:10:24
Category: RSS

Kamada Q1 Results: Double-Digit Growth, Company Reiterates Guidance As It Hits Multiple Milestones Including Plasma Business Expansion - Kamada ( NASDAQ:KMDA )

Kamada Ltd. KMDA recently reported earnings for the first quarter of 2025, which saw revenue up 17% and Adjusted EBITDA up 54% year-over-year. The results help position Kamada to drive growth organically, as well as through acquisitions and/or in-licensing deals.

Source: www.benzinga.com
June 10, 2025 | 12:13:43
Category: News

Comscore and Adelaide Expand Access to High-Quality, Attention-Optimized Curated Deals across PubMatic's platform

New collaboration combines Comscore's trusted inventory rankings with Adelaide's attention metrics, enabling advertisers to drive higher engagement and maximize campaign impact New collaboration combines Comscore's trusted inventory rankings with Adelaide's attention metrics, enabling ...

Source: www.globenewswire.com
June 10, 2025 | 12:15:00
Category: News

Comscore and Adelaide Expand Access to High-Quality, Attention-Optimized Curated Deals across PubMatic's platform - comScore ( NASDAQ:SCOR )

RESTON, Va., June 10, 2025 ( GLOBE NEWSWIRE ) -- Comscore SCOR, a global leader in measuring and analyzing consumer behaviors, today announced the expansion of its Comscore-Certified Deal IDs to include Adelaide's attention-based metric in PubMatic's premium sell-side supply including many of ...

Source: www.benzinga.com
June 10, 2025 | 12:15:00
Category: General

© Natavest 2025 - 2026